Cargando…

Sex steroids and cardiovascular disease

As men grow older, testosterone (T) levels decline and the significance of this change is debated. The evidence supporting a causal role for lower circulating T, or its metabolites dihydrotestosterone (DHT) and estradiol, in the genesis of atherosclerosis and cardiovascular disease (CVD) in men is l...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yeap, Bu Beng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955333/ https://www.ncbi.nlm.nih.gov/pubmed/24407188 http://dx.doi.org/10.4103/1008-682X.122357

Ejemplares similares

Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men
por: Yeap, Bu B
Publicado: (2018)

Sex steroids and glucose metabolism
por: Allan, Carolyn A
Publicado: (2014)

Conclusions about testosterone therapy and cardiovascular risk
por: Anawalt, Bradley D, et al.
Publicado: (2018)

Why is understanding the relationship of testosterone to cardiovascular risk so important?
por: Yeap, Bu B, et al.
Publicado: (2018)

Sex differences in acute cardiovascular care: a review and needs assessment
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2021)

TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019)

MicroRNA and Cardiovascular Diseases
por: Çakmak, Hüseyin Altuğ, et al.
Publicado: (2020)

Mesenchymal stromal cells for cardiovascular disease
por: Copland, Ian B.
Publicado: (2011)

Sexual counseling and cardiovascular disease: practical approaches
por: Steinke, Elaine E, et al.
Publicado: (2015)

Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
por: Stein, Anna, et al.
Publicado: (2022)

Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use
por: McBride, J Abram, et al.
Publicado: (2016)

Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting
por: Kumar, Raj
Publicado: (2016)

An overview of lymphatic vessels and their emerging role in cardiovascular disease
por: Jones, Dennis, et al.
Publicado: (2011)

High density lipoproteins-based therapies for cardiovascular disease
por: Gao, Xuan, et al.
Publicado: (2010)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Developmental onset of cardiovascular disease—Could the proof be in the placenta?
por: D'Errico, Jeanine N., et al.
Publicado: (2019)

Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease
por: Glerup, Simon, et al.
Publicado: (2017)

Antiplatelet therapy in cardiovascular disease: Current status and future directions
por: Passacquale, Gabriella, et al.
Publicado: (2022)

Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease
por: Paeslack, Nadja, et al.
Publicado: (2022)

Non-Steroidal Anti-Inflammatory Drugs and Cognitive Function: Are Prostaglandins at the Heart of Cognitive Impairment in Dementia and Delirium ?
por: Cunningham, Colm, et al.
Publicado: (2011)

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
por: Zoccali, Carmine, et al.
Publicado: (2023)

An update on the roles of immune system-derived microRNAs in cardiovascular diseases
por: Roberts, Luke B, et al.
Publicado: (2021)

Genetic Diversity on the Sex Chromosomes
por: Wilson Sayres, Melissa A
Publicado: (2018)

3-Ketosteroid 9α-hydroxylase enzymes: Rieske non-heme monooxygenases essential for bacterial steroid degradation
por: Petrusma, Mirjan, et al.
Publicado: (2014)

NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies
por: Sirker, Alexander, et al.
Publicado: (2011)

Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases
por: Paloschi, Valentina, et al.
Publicado: (2021)

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Sex determination in mammalian germ cells
por: Spiller, Cassy M, et al.
Publicado: (2015)

The impact of different forms of exercise on circulating endothelial progenitor cells in cardiovascular and metabolic disease
por: Ferentinos, Panagiotis, et al.
Publicado: (2022)

Evolution of sex in crops: recurrent scrap and rebuild
por: Masuda, Kanae, et al.
Publicado: (2023)

Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
por: Aimo, Alberto, et al.
Publicado: (2020)

Testosterone deficiency and cardiovascular mortality
por: Morgentaler, Abraham
Publicado: (2015)

Sex differences in mechanisms of cardiac excitation–contraction coupling
por: Parks, Randi J., et al.
Publicado: (2013)

Sex Chromosome Evolution: So Many Exceptions to the Rules
por: Furman, Benjamin L S, et al.
Publicado: (2020)

Salt and cardiovascular disease in PURE: A large sample size cannot make up for erroneous estimations
por: Tan, Monique, et al.
Publicado: (2018)

Cardiovascular dysfunction in patients with liver cirrhosis
por: Fede, Giuseppe, et al.
Publicado: (2015)

Cardiovascular disease and male sexual dysfunction
por: Miner, Martin, et al.
Publicado: (2015)

Systemic lupus erythematosus and cardiovascular disease
por: Ruilope, Luis M., et al.
Publicado: (2020)

Prevention of cardiovascular disease: are we successful?( )
por: De Backer, Guy
Publicado: (2022)

Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans
por: Ying, Zhixiong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4pbt7j5h7o5sobrshjnn032gp2